Arrow Generiques competitive analysis

Latest publications and patents of Arrow Generiques New

Explore the latest publications and patents granted to Arrow Generiques, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Arrow Generiques against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENAug 29, 2023
Rapamycin Derivative For Treating Pancreas CancerNOVARTISJun 1, 2020
Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated AngiogenesisNOVARTISFeb 24, 2020

Latest PTAB cases involving Arrow Generiques

Discover the latest PTAB cases involving Arrow Generiques, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Arrow Generiques with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ARROW GENERIQUES2 - - - Highly Aggressive
NOVARTIS6406 - 21Defensive